Biotech Industry Advised To Prepare For Incoming EU AI Regulation
Executive Summary
The artificial intelligence revolution has arrived, but are drug and device companies ready to meet the expectations of regulators? Lawyer Vincenzo Salvatore outlines the EU regulatory and policy developments that are relevant to the use of AI in the medical product lifecycle.